Carcinoid Tumor – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Carcinoid Tumor – Drugs In Development, 2024 report and make more profitable business decisions.
Carcinoid tumors are slow-growing tumors arising from neuroendocrine cells and capable of secreting a variety of peptides and neuroamines. The common primary sites are the gastrointestinal (GI) tract, tracheobronchial tree, ovaries, and kidneys. The most common location of carcinoids is the small intestine. The term carcinoid is usually used for well-differentiated and low- to intermediate-grade neuroendocrine tumors.
The Carcinoid Tumor drugs in development market research report provide comprehensive information on the therapeutics under development for Carcinoid Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Carcinoid Tumor and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Carcinoid Tumor | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 10 molecules, with 9 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Carcinoid Tumor therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Carcinoid Tumor pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Carcinoid Tumor treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Agastiya Biotech LLCAquestive Therapeutics Inc
BriaCell Therapeutics Corp
Chiesi Farmaceutici SpA
Crinetics Pharmaceuticals Inc
Exelixis Inc
Imagine Pharma LLC
Loxo Oncology Inc
Max Delbruck Center for Molecular Medicine
Seneca Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Carcinoid Tumor reports